On July 17, Oscar Health fell 5.46% in regular trading, trading at $28.94/share, with turnover of $73.73 million. On the news front, the company has recently seen a wave of insider ownership changes and proposed securities sale filings, triggering selling pressure on the stock.

Regulatory filings reveal a concentrated cluster of Form 4 (statement of changes in beneficial ownership) and Form 144 (proposed sale of securities) submissions spanning from early June through mid-July. Notably, the Life & Health Insurance sector performed steadily on the same day, with Prudential up 1.99%, MetLife up 1.01%, and Aflac up 1.25%, indicating the weakness is company-specific rather than sector-driven.

Oscar Health is a healthcare technology company offering ACA health plans through a full-stack technology platform. The company posted Q1 EPS of $2.07, significantly beating estimates, and guided full-year revenue of $18.7B–$19.0B. Its CTO transitioned to an advisory role in early June. The next earnings report is expected on August 6.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)